Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,140.50
+10.80 (0.96%)
Jan 28, 2026, 3:20 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 656.13 billion as of January 28, 2026. Its market cap has decreased by -12.93% in one year.
Market Cap
656.13B
Enterprise Value
645.08B
Revenue
325.14B
Ranking
n/a
PE Ratio
19.17
Stock Price
1,140.50
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 656.13B, an increase of 6,732.37%. That is a compound annual growth rate of 19.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 656.13B | -4.51% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.60T |
| Cipla | 1.06T |
| Zydus Lifesciences | 887.50B |
| Mankind Pharma | 870.03B |
| Alkem Laboratories | 687.56B |
| Glenmark Pharmaceuticals | 555.29B |
| Laurus Labs | 548.71B |
| Ipca Laboratories | 371.12B |